Results 141 to 150 of about 530,851 (257)

Notification that new names of prokaryotes, new combinations and new taxonomic opinions have appeared in volume 75, part 12 of the <i>IJSEM</i>. [PDF]

Int J Syst Evol Microbiol
Oren A, Göker M.
europepmc   +1 more source

New Names for Three Penicillium Strains Based on Updated Barcoding and Phylogenetic Analyses. [PDF]

Microbiol Resour Announc, 2021
Yin G, Jurick WM, Zhao G, Bennett JW.
europepmc   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Validation List no. 224. Valid publication of new names and new combinations effectively published outside the IJSEM. [PDF]

Int J Syst Evol Microbiol
Oren A, Göker M.
europepmc   +1 more source

Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance. [PDF]

Clin Chem, 2021
Wiederhold NP.
europepmc   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Validation list no. 225: valid publication of new names and new combinations effectively published outside the <i>IJSEM</i>. [PDF]

Int J Syst Evol Microbiol
Oren A, Göker M.
europepmc   +1 more source

New Names for Fungi of Medical Importance: Can We Have Our Cake and Eat It Too? [PDF]

J Clin Microbiol, 2021
Kidd SE, Halliday CL, McMullan B, Chen SC, Elvy J.   +4 more
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Notification that new names of prokaryotes, new combinations and new taxonomic opinions have appeared in volume 75, part 7 of the <i>IJSEM</i>. [PDF]

Int J Syst Evol Microbiol
Oren A, Göker M.
europepmc   +1 more source